YYÜ GCRIS Basic veritabanının içerik oluşturulması ve kurulumu Research Ecosystems (https://www.researchecosystems.com) tarafından devam etmektedir. Bu süreçte gördüğünüz verilerde eksikler olabilir.
 

Urinary Beta-2 Microglobulin in Renal Dysfunction Associated With Hypothyroidism

dc.authorid Topal, Cevat/0000-0001-7539-8066
dc.authorscopusid 6602819950
dc.authorscopusid 6603171493
dc.authorscopusid 7102666119
dc.authorscopusid 6603300537
dc.authorscopusid 16744938800
dc.authorwosid Sekeroglu, Ramazan/Htn-6390-2023
dc.contributor.author Algün, E
dc.contributor.author Topal, C
dc.contributor.author Öztürk, M
dc.contributor.author Sekeroglu, MR
dc.contributor.author Durmus, A
dc.date.accessioned 2025-05-10T17:39:09Z
dc.date.available 2025-05-10T17:39:09Z
dc.date.issued 2004
dc.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
dc.department-temp Yuzuncu Yil Univ, Fac Med, Dept Endocrinol, Van, Turkey; Yuzuncu Yil Univ, Dept Nephrol, Van, Turkey; Yuzuncu Yil Univ, Dept Biochem, Van, Turkey; Yuzuncu Yil Univ, Dept Internal Med, Van, Turkey en_US
dc.description Topal, Cevat/0000-0001-7539-8066 en_US
dc.description.abstract Hypothyroidism is associated with a number of functional renal disorders primarily affecting water and salt handling. In this study, we aim to investigate functional renal disorders in overt and subclinical hypothyroidism. We utilised urinary beta-2 microglobulin (beta2M) as a sensitive marker of tubular dysfunction. Urinary beta2M excretion and tests for renal functions were repeated before and after T4 replacement therapy. Forty-four patients (28 with overt disease, 16 with subclinical disease) and 31 healthy control subjects were involved in the study. There was a significant increase in urinary beta2M in both overt and subclinical hypothyroidism (p < 0.05 in both). TSH levels were correlated with beta2M excretion. Effects of hypothyroidism on renal functions were readily reversible by 3 weeks of thyroid hormone replacement therapy. Urinary beta2M was a sensitive marker of renal tubular dysfunction associated with overt and subclinical hypothyroidism. (C) 2004 Black-well Publishing Ltd. en_US
dc.description.woscitationindex Science Citation Index Expanded
dc.identifier.doi 10.1111/j.1368-5031.2004.0014.x
dc.identifier.endpage 243 en_US
dc.identifier.issn 1368-5031
dc.identifier.issn 1742-1241
dc.identifier.issue 3 en_US
dc.identifier.pmid 15117089
dc.identifier.scopus 2-s2.0-2342423181
dc.identifier.scopusquality Q1
dc.identifier.startpage 240 en_US
dc.identifier.uri https://doi.org/10.1111/j.1368-5031.2004.0014.x
dc.identifier.uri https://hdl.handle.net/20.500.14720/14808
dc.identifier.volume 58 en_US
dc.identifier.wos WOS:000221046600003
dc.identifier.wosquality Q3
dc.language.iso en en_US
dc.publisher Wiley en_US
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.subject Hypothyroidism en_US
dc.subject Renal Dysfunction en_US
dc.subject Beta-2 Microglobulin en_US
dc.title Urinary Beta-2 Microglobulin in Renal Dysfunction Associated With Hypothyroidism en_US
dc.type Article en_US

Files